Clinical Trial Update: A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating LM-101 Injection in patients with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LM-101 Injection (LM-101)

Snippet

Sponsor: LaNova Medicines Limited | Conditions: Malignant Tumors | Phase 1, Phase 2 | Status: RECRUITING